ClinConnect ClinConnect Logo
Search / Trial NCT05114005

Tango for Neuropathy Among Breast Cancer Survivors

Launched by OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER · Oct 29, 2021

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called "Tango for Neuropathy Among Breast Cancer Survivors," is exploring how group dance classes, specifically tango, can help improve the quality of life and physical health for breast cancer survivors experiencing neuropathy. Neuropathy is a condition that can cause pain, tingling, or numbness, often in the hands and feet. The researchers want to see if dancing in a supportive group setting can enhance both physical abilities, like balance, and emotional well-being for these survivors.

To participate, you need to be a breast cancer survivor who has completed certain chemotherapy treatments at least three months ago and is experiencing symptoms of neuropathy. You should also be able to follow directions during the dance classes. However, if you have certain conditions, like uncontrolled diabetes or specific orthopedic issues, you may not be eligible. Participants can expect to join dance classes that not only focus on movement but also promote social interaction and support. This trial is currently recruiting participants of all ages, and it offers a unique opportunity to potentially improve both physical and emotional health through dance.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Breast cancer survivor stage I-III
  • Symptomatic for neuropathy
  • postural control outside 70% CI for adults who are middle-aged without neurotrauma
  • having completed taxane-based chemotherapy treatment at least 3 months ago;
  • able to understand and comply with directions associated with testing and study treatments.
  • Exclusion Criteria:
  • Pre-existing vestibular deficit;
  • poorly controlled diabetes (hgA1C \> 8);
  • non-ambulatory or lower extremity amputation (assistive devices allowed);
  • use of cytotoxic or immunotherapy during study (endocrine therapy allowed);
  • participation in physical therapy during the study;
  • contraindication to participate in Tango due to orthopedic issue (e.g., herniated vertebral disc);

About Ohio State University Comprehensive Cancer Center

The Ohio State University Comprehensive Cancer Center (OSUCCC) is a leading institution dedicated to advancing cancer research, treatment, and education. As a National Cancer Institute-designated comprehensive cancer center, OSUCCC integrates cutting-edge research with clinical practice to develop innovative therapies and improve patient outcomes. With a collaborative approach that unites scientists and clinicians, OSUCCC focuses on personalized medicine, cancer prevention, and community outreach, striving to enhance the understanding of cancer biology and provide hope to patients through groundbreaking clinical trials and comprehensive care programs.

Locations

Columbus, Ohio, United States

Patients applied

0 patients applied

Trial Officials

Lise Worthen-Chaudhari, PhD, MFA

Principal Investigator

Ohio State University Comprehensive Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials